webinar register page

Webinar banner
The Future of UK MedTech Regulation and Access
The UK is leveraging its position outside of the EU to find pragmatic ways to accelerate access to the best new technologies, including artificial intelligence and machine learning as a medical device. This includes a revised regulatory framework, world-leading health technology assessment, and a new MedTech funding mandate. Join us to learn about the UK’s plans and share your own vision for the future.

The discussion will be moderated by the Medical Alley Association and will include opening remarks by British Consul General Alan Gogbashian, followed by a Q&A discussion with Professor Peter Groves, Chairman of the Medicines and Healthcare products Regulatory Agency’s (MHRA) Devices Expert Advisory Committee (DEAC), and Graeme Tunbridge, Director of Devices at Medicines and Healthcare products Regulatory Agency (MHRA).

Apr 23, 2021 09:00 AM in Central Time (US and Canada)

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Alan Gogbashian
British Consul General in Chicago
Alan leads the UK’s engagement across the Midwest. Alan has been a member of the British diplomatic service since 2008. His most recent roles have included Deputy Ambassador to Morocco and Mauritania, Deputy Director Americas, and Head of International Human Resources. Before joining the Foreign and Commonwealth Office, Alan worked in corporate law in London and Paris, international development, and the life sciences sector.
Graeme Tunbridge
Director of Devices at Medicines and Healthcare Products Regulatory Agency
Graeme first joined the MHRA in 2011 and has spent much of his time at the MHRA negotiating, and now implementing, a package of measures to strengthen the regulation of medical devices. Graeme has been a civil servant for 15 years and spent his early career working on healthcare policy. He has previously held Deputy Director roles at the Department of Health and spent 18 months as Private Secretary to the Secretary of State for Health. He has a Master’s degree in biochemistry from the University of Oxford.
Peter Groves MD, FRCP
Chairman of the Medicines and Healthcare products Regulatory Agency’s (MHRA) Devices Expert Advisory Committee (DEAC)
Professor Peter Groves is a Consultant Interventional Cardiologist based at the University Hospital of Wales. He served as Clinical Director of Cardiothoracic Services from 2002 to 2009. Professor Groves undertakes percutaneous cardiac procedures for structural and coronary heart disease and leads the Structural Heart Disease Interventional Programme in South-East Wales. Professor Groves is past-President of the Welsh Cardiovascular Society and previous Council member of the British Cardiovascular Society. He represents the Welsh Government as the chairman of the MHRA Devices Expert Advisory Committee (DEAC) and has worked with NICE since 2006. Professor Groves was appointed as Chair of the Medical Technologies Advisory Committee in 2016 and served to March 2021.